Mankind Pharma Shareholding

Mankind Pharma Ltd Shareholding Pattern

The Mankind Pharma Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Mankind Pharma Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Mankind Pharma Ltd (NSE: MANKIND, BSE: 543904) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Mankind Pharma Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Mankind Pharma Ltd Shareholding Pattern (Latest)

The latest Mankind Pharma Ltd shareholding for Dec 2025 is:

• Promoters: 72.66%
• FII: 11.34%
• DII: 13.25%
• Public: 2.75%
• Government: 0%

A slight decline in promoter holding may indicate stake dilution or strategic selling.

Mankind Pharma Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Mankind Pharma Ltd.

• Dec 2025: 72.66%
• Sept 2025: 72.67%
• Jun 2025: 72.68%
• Mar 2025: 72.70%
• Dec 2024: 72.71%

Promoter stake remains largely stable, showing consistent ownership structure.

Mankind Pharma Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Mankind Pharma Ltd.

• Dec 2025: 11.34%
• Sept 2025: 12.84%
• Jun 2025: 13.07%
• Mar 2025: 12.92%
• Dec 2024: 13.34%

FII holding has declined, suggesting cautious sentiment among foreign investors.

Mankind Pharma Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Dec 2025: 13.25%
• Sept 2025: 11.92%
• Jun 2025: 11.50%
• Mar 2025: 11.48%
• Dec 2024: 11.06%

DII stake in Mankind Pharma Ltd has increased over time, indicating growing domestic institutional confidence.

Mankind Pharma Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Dec 2025: 2.75%
• Sept 2025: 2.57%
• Jun 2025: 2.75%
• Mar 2025: 2.90%
• Dec 2024: 2.90%

Public participation in Mankind Pharma Ltd has increased, indicating rising retail investor interest.

Mankind Pharma Ltd Government Holding

Government holding in Mankind Pharma Ltd currently stands at 0%.

Mankind Pharma Ltd operates without significant government ownership.

Mankind Pharma Ltd Shareholding Analysis Summary

The Mankind Pharma Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Mankind Pharma Ltd shows strong promoter and domestic institutional confidence, which is positive for long-term investors.

Regular monitoring of the Mankind Pharma Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.